Association of lipoprotein(a) with ASCVD risk in women by menopausal status: the UK Biobank
American Journal of Preventive Cardiology · 2026-04 · 26 · 101465
DOI: 10.1016/j.ajpc.2026.101465 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-04. Verfasst von Mikaila P Reyes und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California San Diego School of Medicine, San Diego, CA, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, University of California San Diego.
Abstract (Originalsprache)
Title: Association of Lipoprotein(a) with ASCVD Risk in Women by Menopausal Status: the UK Biobank Author names: Mikaila P. Reyes1, Alexander C. Razavi2, Harpreet S. Bhatia3 Affiliations: 1University of California San Diego School of Medicine, San Diego, CA, USA; mpr006@health.ucsd.edu2Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA; alexander.c.razavi@emory.edu3Division of Cardiovascular Medicine, University of California San Diego, CA, USA; hsbhatia@health.ucsd.edu ABSTRACTIntroduction: Lipoprotein(a) [Lp(a)] is a predominantly genetically determined risk factor for atherosclerotic cardiovascular disease (ASCVD); however, menopause is one of the few conditions that can lead to an increase in Lp(a). We aimed to investigate whether menopause status modifies the association between Lp(a) and ASCVD risk.
Methods
A total of 153,890 pre- and post-menopausal women free of prior ASCVD were studied using data from the UK Biobank. Menopause status was based on self-report while ASCVD was a composite outcome based on ICD10-coded myocardial infarction, stroke or cardiovascular death. Multivariable Cox proportional hazards models evaluated the association between Lp(a) and incident ASCVD events stratified by menopause status.
Results
The median age was 56.1 years, with 60% of women post-menopausal. Median Lp(a) was 22.5 [10.1, 62.1] nmol/L, 21% had Lp(a) >75 nmol/L, and 12% had Lp(a) ≥125 nmol/L. There were 5,160 (3.4%) incident ASCVD events during a median follow up of 13.7 years. Standard deviation increases in Lp(a) were associated with higher risk of ASCVD events among pre-menopausal (HR 1.06, 95% CI 1.00-1.12, p = 0.041) and post-menopausal women (HR 1.06, 95% CI 1.03 - 1.09, p 125 nmol/L (HR 1.15, 95% CI 1.05, 1.26, p = 0.003) were associated with increased ASCVD risk when compared to Lp(a) 0.05).
Conclusion
Lp(a) is an independent risk factor for ASCVD events for both pre- and post-menopausal women.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of California San Diego School of Medicine, San Diego, CA, USA.
- Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.
- Division of Cardiovascular Medicine, University of California San Diego, CA, USA.
Förderung
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- University of California San Diego
- National Institutes of Health
Zitieren
APA
Reyes, M. P., Razavi, A. C., & Bhatia, H. S. (2026). Association of lipoprotein(a) with ASCVD risk in women by menopausal status: the UK Biobank. American Journal of Preventive Cardiology, 26, 101465. https://doi.org/10.1016/j.ajpc.2026.101465
Vancouver
Reyes MP, Razavi AC, Bhatia HS. Association of lipoprotein(a) with ASCVD risk in women by menopausal status: the UK Biobank. American Journal of Preventive Cardiology. 2026;26:101465. doi:10.1016/j.ajpc.2026.101465
BibTeX
@article{Reyes2026,
author = {Reyes, Mikaila P and Razavi, Alexander C and Bhatia, Harpreet S},
title = {Association of lipoprotein(a) with ASCVD risk in women by menopausal status: the UK Biobank},
journal = {American Journal of Preventive Cardiology},
year = {2026},
volume = {26},
pages = {101465},
doi = {10.1016/j.ajpc.2026.101465}
}
EUVIMED